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Abstract: Introduction: Faster reconstruction of patients’ masticatory systems is the aim of modern dentistry. A number 
of studies have indicated that application of growth factors to the surface of a dental implant leads to accelerated and en-
hanced osseointegration. The objective of the present study was to investigate the effect of plasma rich in growth factors 
on peri-implant bone healing. 
Materials and Methods: For the purpose of this study, two healthy, mixed-breed canines were selected, and the premolars 
were extracted from both sides of the mandible. Three months after premolar removal, 12 implants, each 5 mm in diame-
ter and 10 mm in length, were placed in osteotomy sites on both sides of the mandible. Prior to placement, plasma rich in 
growth factors was applied to the surfaces of six implants, while the other six were used without plasma rich in growth 
factors. The implants were removed after 12 weeks along with the bone surrounding the sites using a trephine bur. One 
mesiodistal section containing the surrounding bone from each implant block, 50 m in diameter, was prepared for his-
tologic and histomorphometric investigation with an optical microscope. 
Results:  The sites with implants treated with plasma rich in growth factors showed more bone-to-implant contact   
compared to control sites. Also, higher values for bone trabecular thickness and bone maturity were recorded for the 
PRGF-treated sites than for the control sites. 
Conclusion: Application of plasma rich in growth factors to the surface of an implant may enhance the bone healing proc-
ess as well as bone-to-implant contact, thereby helping to achieve faster osseointegration. 
Keywords: Plasma Rich in Growth Factors (PRGF), Bone-to-Implant Contact (BIC), Histomorphometric Analysis, Histologic 
Examination, Osteo Implant Corporation. 
INTRODUCTION 
Over the past few decades, the most common remedy for 
edentulous mandibles was reconstruction by removable den-
tures, which caused functional and esthetic problems in addi-
tion to inconvenience for the patients. Nowadays, dental im-
plants are frequently used to support fixed prostheses or re-
movable overdentures [1]. An ongoing problem with implant 
treatment, however, is the time needed for the peri-implant 
bone to heal; loading of the implants is usually delayed and 
patients must continue to be edentulous for long periods. To 
address these problems, many efforts have been directed 
toward improving the macroscopic and microscopic struc-
tures of implant surfaces in an attempt to accelerate and en-
hance osseointegration; these investigations have yielded 
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positive results. In addition, tissue engineering principles 
have been invoked by other scientists in the use of biological 
constituents such as growth factors or bone-specific proteins, 
including bone morphogenetic proteins, on implant surfaces 
or inside localized alveolar bone defects to enhance the rate 
of bone formation. Numerous studies have been performed 
on platelet-derived growth factors [2-6]. These studies have 
also demonstrated successful results. 
The idea behind these studies is that growth factors are 
capable of creating an active and dynamic environment on 
the implant surface that, in turn, can encourage the creation 
of new peri-implant bone [7, 8]. Investigations in human, 
animal, and in vitro models have shown that the application 
of growth factors such as platelet-rich plasma (PRP) or 
plasma rich in growth factors (PRGF), either directly to 
autogenous bone or allografts, xenografts, or alloplasts or 
inside bone defects, may lead to faster healing rates and en-
hanced bone formation [9-19]. PRGF always and exclusively Investigation of Peri-Implant Bone Healing Using Autologous Plasma  The Open Dentistry Journal, 2011, Volume 5     169 
uses a patient’s own autologous proteins, which are prepared 
at the same time they are used. PRGF contains platelet and 
plasma growth factors involved in the repair process; it also 
contains sticky plasma proteins such as fibrin, fibronectin, 
and vitronectin, among others [6, 18]. Some researchers have 
even reported that the high concentration of transforming 
growth factor   (TGF-) present in platelets via PRP can 
give rise to better repair of the emerging tissue and to en-
hanced bone reconstruction. They claim that the growth fac-
tors released by platelets play an important role in improving 
the bone response and in the transformation of marrow bone 
cells into osteoblasts [20]. 
In contrast, some researchers have challenged the appli-
cation of growth factors to bone tissue for enhancing bone 
reconstruction [21-27]. Giovanini et al. [25] created four 16-
mm
2 bone defects in the calvaria of 21 rabbits. The surgical 
defects were treated with either particulate autograft, particu-
late autograft mixed with PRP, or PRP alone. The histomor-
phometric results demonstrated intensive deposition of fi-
brous tissue, while bone deposition was hindered in PRP 
groups. These results coincided with higher values of TGF- 
on the PRP sample. The authors explained that the higher 
levels of TGF- associated with the expression of collagen 
III, a smooth muscle actin, on defects treated with PRP sug-
gest that this biomaterial induces an effect that can be con-
sidered similar to that of a fibroproliferative disorder. Ar-
pornmaeklong et al. [26] compared the effects of PRP and 
bone morphogenetic protein 2 in vitro. They reported that 
PRP showed a dose-dependent stimulation of cell prolifera-
tion while reducing alkaline phosphatase activity and cal-
cium deposition in the culture. Bone morphogenetic protein 
2 led to an opposite cell response and induced the highest 
alkaline phosphatase activity and mineral deposition. These 
data suggest that PRP inhibited osteogenic differentiation of 
marrow-derived preosteoblasts in a dose-dependent manner. 
The authors further claimed that the useful clinical effects 
observed in applications of PRP may have been the result of 
one of the following two causes: (1) formation of an autolo-
gous fibrin gel, which may have given rise to stabilization of 
the graft material and the blood coagulate due to its adhesive 
strength; or (2) the strong mitogenic properties of PRP for 
soft tissue cells, which improve reconstruction treatments 
because of the associated faster repair process and reduced 
likelihood of wound dehiscence.  
Because of the controversy regarding the effectiveness of 
growth factors in enhancing peri-implant bone healing, the 
present study sought to evaluate the effects of autogenous 
PRGF on the quantity and quality of peri-implant bone re-
construction in the canine mandible. 
MATERIALS AND METHODS 
Two male mixed-breed canines (each around 25 kg) were 
selected for this split-mouth study. Animal selection, man-
agement, and preparation and surgical protocols were 
adopted from a study of Wikesjo et al. [28] and were in ac-
cordance with the instructions of the Medical Ethics and 
Institutional Animal Care Committee of Isfahan University 
of Medical Sciences, Isfahan, Iran. 
Surgical Procedure 
The animals used in this study were weighed 3 months 
after extraction of the premolars on both sides of their man-
dibles. A mixture of 10% ketamine hydrochloride (40 
mg/kg) and 2% xylazine (5 mg/kg) (Alfasan International, 
Woerden, The Netherlands) was administered by deep mus-
cular injection to induce anesthesia. An intubation tube con-
taining a combination of oxygen and 15% halothane was 
used to maintain anesthesia. Immediately after the anesthetic 
took effect, blood samples were taken from the tibia and 
transferred to a centrifuge. 
While the blood sample was being prepared, the surgeon 
made crestal incisions in the edentulous area on each side of 
the mandible to create three osteotomy sites, each 5 mm in 
diameter and 10 mm in length. The surgeon then placed 
three OIC implants (Osteo Implant Corporation, New Castle, 
PA, USA) in a submerged technique inside the osteotomy 
sites in the right mandible. The edges of the reflected flap 
were then sutured using an interrupted technique. On the left 
side of the mandible, PRGF was injected into the prepared 
sites, and three more implants were first immersed in PRGF 
and then placed into the osteotomy sites.  
The same procedure was repeated in the other dog, ex-
cept that the implants that had been immersed in PRGF were 
placed in the right side of the mandible.  
During the first 12 weeks after implant placement sur-
gery, infection control was accomplished by daily topical 
application of 2% chlorhexidine solution coupled with ad-
ministration of a broad-spectrum antibiotic (a combination of 
penicillin G 10,000 IU/kg and streptomycin 100 mg/kg, 
Hayyan Pharmaceutical Co, Tehran, Iran). The animals were 
fed soft food supplemented with vitamins throughout the 
study period [29].  
PRGF Preparation 
The creation and application of PRGF followed the pro-
tocol of Anitua et al. [6]. A blood sample of 20 mL was 
taken from the saphenous vein in the tibia and directly trans-
ferred to the PRGF System (BTI Biotechnology, San Anto-
nio, Spain). For PRGF preparation, a one-stage centrifuge 
was used at a low speed (460g) for 15 to 20 minutes at room 
temperature. Sterile tubes containing a 38% sodium citrate 
solution were used to prevent blood coagulation. For activa-
tion and aggregation of platelets, 50 mL of 10% calcium 
chloride was used for each milliliter of PRGF. After the 
blood sample had been centrifuged and the plasma had been 
separated from the red and white blood cells, the plasma in 
each tube was fractionated into three distinct fractions. Frac-
tion 3, designated as PRGF, is the layer immediately over a 
layer of red blood cells and contains a considerable amount 
of platelet-derived growth factors [30]. 
Histologic Preparation 
Twelve weeks after the implants had been placed, biopsy 
blocks containing the implants and the surrounding bone 
were removed using a trephine bur (no. 8; Meisinger, Neuss, 
Germany). Each specimen was kept for 10 days in a coded 
package containing 10% formalin solution and then dehy-
drated with alcohol. The specimens were then transferred 
into a transparent cold-setting acrylic resin (Fig. 1). The 170     The Open Dentistry Journal, 2011, Volume 5  Birang et al. 
ground histologic sections were prepared to obtain mesiodis-
tal sections 50 m thick and further prepared according to 
the Donath method [31]. The sections were sent for examina-
tion by an oral pathologist with an optical microscope 
(BX51; Olympus Co, Tokyo, Japan). The parameters re-
corded for each section included: (1) inflammation rate 
(scored as follows: 0, none or few inflammatory cells, no 
reaction; 1, < 25 cells, mild reaction; 2, 25 to 125 cells, mod-
erate reaction; 3, > or = 125 cells, severe reaction [31,32]); 
(2) type of osseous tissue generated (eg, lamellar bone, 
woven bone); (3) thickness of bone trabeculae; and (4) bone-
to-implant contact (BIC) percentage. BIC is a histologic 
concept traditionally evaluated by calculating the amount of 
the implant surface directly attached to mineralized bone 
without the interposition of soft connective tissue. Three 
sections of each specimen were examined, and the average 
of the three measurements was reported as the BIC for that 
implant. The predominant cell type, calcification, and thick-
ness of the fibrous connective tissue were also recorded. 
Statistical Analysis 
Because only two animals were used in this study, statis-
tical analysis could not be performed. Descriptive analyses 
were performed. 
RESULTS 
In this experiment, healing proceeded without difficulty 
in both animals; no infections or implant or bone exposures 
were observed in any of the implant sites. 
A comparison of PRGF-treated and control sites revealed 
identical inflammation rates. 
Bone maturity was greater in the PRGF group than in the 
control group (Figs 1 to 4, Table 1). Moreover, it was possi-
ble to see lamellar bone around the PRGF-treated implants 
under polarized microscopy (Fig. 3). 
The thickness of the bone trabeculae was greater in the 
PRGF-treated sites than in the control sites (Table 2).  
Fig. (2a and 2b) show the presence of well-ordered trabecu-
lae with marginal osteoblastic activity in the PRGF section, 
compared to the control. 
 
Fig. (1). (Left) Control sample and (right) PRGF-treated sample 
within the cold resin (40X magnification).  
 
Fig. (2). Newly formed bone at (A) low magnification (40X) and 
(B) high magnification (100X). It is possible to see newly formed 
bone (woven bone, WB, and lamellar bone, LB) and the presence 
of well-ordered trabeculae with marginal osteoblastic activitiy in 
the PRGF section compared to the control (basic fuchsin– toluidine 
blue). C = connective tissue; OB = osteoblast; BM = bone marrow; 
T = trabeculae.  
 
Fig. (3). PRGF section at 12 weeks. It is possible to see lamellar 
bone around the PRGF-treated implant with polarized microscope 
(100X). HS = Haversian system; BM = bone marrow; LB = lamel-
lar bone; OB = old bone; C = connective tissue; Im = implant.  
 
Fig. (4). Comparison of BIC (length of direct bone-to-implant con-
tact as a percengae of the implant surface) in (A) PRGF-treated and 
(B) control samples. In the PRGF-treated sample, almost complete 
contact of the bone within the thread is seen (basic fuchsin–
toluidine blue; original magnification 100X).  
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Comparisons were also made between the experimental 
and control groups in terms of BIC percentage. BIC percent-
age was higher in the PRGF group (Table 3, Fig. 4). 
DISCUSSION 
Despite controversy regarding their effectiveness, growth 
factors are frequently used in medicine and dentistry. In den-
tistry, they are used as PRP and PRGF to treat problems such 
as periodontal infrabony defects, peri-implant bone defects, 
and denuded dental roots, and in procedures including maxil-
lary sinus augmentation and osteodistraction [32]. However, 
more recently, the efficacy of growth factors in bone tissue 
reconstruction has been seriously challenged [21-25]. 
The present study was designed on the basis of histologic 
and histometric evaluations to investigate the effect of PRGF 
on the healing process of peri-implant bone in the canine 
mandible. The parameters used to evaluate bone healing con-
sisted of inflammation rate, the maturity of newly generated 
bone, BIC percentage, and bone trabecular thickness. 
The PRGF and control treatments exhibited similar rates 
of inflammation over the 12 weeks following surgery. The 
severity of inflammation was evaluated in most cases as 
grade 0 (no inflammation). This finding is in agreement with 
the findings reported by Fontana et al. [15]. 
The maturity of newly regenerated bone was investigated 
during the same 12-week period. A greater amount of mature 
bone was observed in the PRGF-treated sites than in the con-
trol sites (Table 1). None of the samples in either group was 
evaluated as grade III (woven bone). This indicates that re-
modeling is a function of time, as also reported by Philippart 
et al. [14]. However, Choi et al. [23] reported different re-
sults in their canine study. Their fluorescence microscopic 
examinations revealed that bone grafts containing PRP ex-
hibited delayed remodeling. Zechner et al. [8] reported the 
time course of local bone formation following the applica-
tion of PRP during implant placement in minipigs. The ani-
mals were sacrificed at 3, 6, and 12 weeks, and undecalcified 
ground sections were prepared. They reported significant 
improvement in the 6-week specimens but not in the 12-
week specimens. These differences in time and dose depend-
ence may be related to the use of different animals and qual-
ity/quantity of PRGF obtained from the animals. 
The data in Table 2 show that thicker bone trabeculae 
were observed around the PRGF-treated implants than 
around the control implants. This finding is in agreement 
with the results reported by Wojtowicz et al. [11] and Fuerst 
et al. [3]. 
In this experiment, application of PRGF to implant sur-
faces gave rise to faster healing of the bone surrounding the 
implant and enhancement of BIC compared to the control 
treatment (PRGF treatment = 59.83% ± 3.1%, control = 
45.67% ± 3.7%) (Table 3). This is in agreement with the 
findings of Fontana et al. [15], Kim et al. [16], and Fuerst  
et al. [3]. In their investigation with minipigs, Fuerst et al. 
[3] placed implants on both sides of the mandible. On one 
side, the implant was treated with platelet-derived growth 
factors before placement, while the other was placed un-
treated. After a period of 4 to 8 weeks, the authors measured 
BIC percentage at both types of sites. During the experimen-
tal period, BIC at the surface of growth factor–treated im-
plant surfaces exhibited a mean value of 55.3%, while the 
mean control BIC was 38.91%. The authors also reported 
that application of platelet-derived growth factors could be 
used to strengthen the anchorage of mandibular implants.  
While the observation of an advantage associated with 
growth factor treatment agrees with the findings of the pre-
sent study, it contradicts those reported by Weibrich et al. 
[22], Schlegel et al. [13], Jensen et al. [24], and others.   
Weibrich et al. [22] carried out an experiment in rabbits to 
investigate the effect of platelets present in PRP on peri-
Table 1. Thickness of Bone Trabeculae at Different Sites 
 Trabecular  Thickness 
Study Group  I  II  III 
PRGF  5 (83.3%)  1 (16.6%)  0 
Control  4 (66.6%)  2 (33.3%)  0 
PRGF = plasma rich in growth factors. Definitions of trabecular thickness grades: Grade I = Thicker than 60 m (thick); grade II = 20–60 m (medium); grade III = thinner than 20 
m (thin). 
Table 2. Maturity of Regenerated Bone at Different Sites 
 Bone  Type 
Study Group  I  II  III 
PRGF  4 (66.6%)  2 (33.3%)  0 
Control  2 (33.3%)  4 (66.6%)  0 
PRGF = plasma rich in growth factors. Definitions of bone type: Grade I = lamellar bone; grade II = lamellar and woven bone; grade III = woven bone. 
Table 3. Means and Standard Errors of BIC Percentage for the 
Different Treatments at 12 Weeks 
Treatment  BIC % (Mean ± SE) 
PRGF 
Control 
59.83 ± 3.1 
45.67 ± 3.7 
BIC = bone-implant contact; PRGF = plasma rich in growth factors. 172     The Open Dentistry Journal, 2011, Volume 5  Birang et al. 
implant bone reconstruction. They reported no differences in 
terms of BIC between the experimental and control groups. 
They also reported that only a very limited range of platelet 
concentration (about 1 million platelets/L) may have posi-
tive effects on bone reconstruction, such that any concentra-
tion below or above this value may have an inhibitory effect. 
They found no tangible differences between the two groups 
with respect to BIC percentage. Schlegel et al. [13] reported 
no considerable effect for PRP when applied for condition-
ing the implant bed. Jensen et al. [24] investigated the use of 
PRP with frozen or processed allografts and titanium im-
plants covered with hydroxyapatite and reported no en-
hancements in osseous regeneration or implant stability. 
The following may be claimed as possible reasons for the 
controversial results reported for the effects of platelet-
derived growth factors: 
1.   The commercial PRP or PRGF preparation systems 
available commercially may use different amounts of 
living platelets as a basis for platelet concentrate. Stud-
ies have reported that the reproduction and differentia-
tion of mesenchymal stem cells are direct functions of 
platelet concentration; hence, the differences in the re-
sults reported [33]. 
2.   The growth factors present in alpha granules will be 
released rapidly; thus, they may lose their effectiveness 
if the PRGF sample is not prepared in an environment 
containing an anticoagulant [34]. 
3.   Differences in the amounts of animal and human blood 
samples taken may result in differences in platelet con-
centrations and, as a result, in the growth factors derived 
[3]. 
4.   Differences in the numbers of specimens and evaluation 
methods employed may cumulatively affect study   
results. 
5.  Animal and clinical studies have shown different results 
with the use of PRP and its effect on bone healing. This 
could be a result of the differences between species; that 
is, differences between species in growth factor 
concentrations or variations in the presence of growth 
factors between the various PRPs [35]. 
A major limitation of this study is in its use of only two 
animals. Although many samples were obtained from the 12 
implants placed, it is possible that subject-related factors 
influenced the findings, since all samples came from only 
two animals. Future animal studies involving PRPs and im-
plant placement should employ a larger number of test ani-
mals to confirm the present results. 
CONCLUSION 
Based on the findings of the present study, it may be 
concluded that application of PRGF to peri-implant bone 
may enhance the healing of bone surrounding implants, in-
cluding bone-to-implant contact. Application of this method 
may, therefore, be effective in enhancing the rate of osseoin-
tegration. Future studies of larger numbers of animals should 
be conducted to confirm the present findings. 
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